MTOR and renal cell carcinoma: Deleted genes in the ES group were enriched in “basal cell carcinoma”, “proteoglycans in cancer”, “biosynthesis of amino acids”, “renal cell carcinoma” and “mTOR signaling pathway” (Supplementary Figure S6B).